Reassessment of Acute Kidney Injury after Cardiac Surgery: A Retrospective Study
The objective of this study was to evaluate the incidence, risk, or protective factors of acute kidney injury (AKI) in patients after cardiac surgery based on the Kidney Disease: Improving Global Outcomes (KDIGO) criteria.
Urinary TIMP-2 and IGFBP7 for the Prediction of Acute Kidney Injury Following Cardiac Surgery
Acute kidney injury (AKI) following cardiac surgery is common and associated with poor patient outcomes. Early risk assessment for development of AKI remains a challenge.
Perioperative Utility of Goal-Directed Therapy in High-Risk Cardiac patients Undergoing Coronary Artery Bypass Grafting: “A Clinical Outcome and Biomarker-Based Study”
Goal-directed therapy (GDT) encompasses guidance of intravenous (IV) fluid and vasopressor/inotropic therapy by cardiac output or similar parameters to help in early recognition and management of high-risk cardiac surgical patients. With the aim of establishing the utility of perioperative GDT using robust clinical and biochemical outcomes, we conducted the present study.
Long-Term Secondary Prevention of Acute Myocardial Infarction (SEPAT) – Guidelines Adherence and Outcome
This study evaluates prevention guideline adherence and outcome of guideline-directed secondary prevention in patients surviving 2 years after acute myocardial infarction (AMI).
A Reminder of Methylene Blue’s Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery
The use of methylene blue should be considered in patients who develop hypotension refractory to standard treatment after cardiac surgery.
Twenty Years of Vasoplegic Syndrome Treatment in Heart Surgery. Methylene Blue Revised
This study was conducted to reassess the concepts established over the past 20 years, in particular in the last 5 years, about the use of methylene blue in the treatment of vasoplegic syndrome in cardiac surgery.
Goal-Directed Therapy Improves the Outcome of High-Risk Cardiac Patients Undergoing Off-Pump Coronary Artery Bypass
The present study was conducted to study the outcome benefits with the combined use of goal-directed therapy (GDT) with off-pump coronary artery bypass (OPCAB) as compared to the conventional hemodynamic management.
Novel Goal-Directed Hemodynamic Optimization Therapy Based on Major Vasopressor during Corrective Cardiac Surgery in Patients with Severe Pulmonary Arterial Hypertension: A Pilot Study
Recent evidence suggests that perioperative goal-directed hemodynamic optimization therapy (GDHOT) significantly improves outcomes in surgery patients. Standard GDHOT is based on major solution volume, vasodilators and inotropic therapy, while novel GDHOT is based on major vasopressor and inotropic therapy.